GleamWall
中文EN

LIVN LivaNova PLC

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1639691 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.7%
TTM net income YoY190.1%
TTM EPS YoY187.7%
Revenue 3-yr CAGR10.5%
Net income 3-yr CAGR308.9%

Margins

Gross margin67.8%
Operating margin10.7%
Net margin13.0%
FCF margin8.6%
EBITDA margin13.0%

Returns

ROE15.5%
ROA7.4%
ROIC (approx.)15.8%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets49.4%
Debt / equity0.22x
Current ratio1.46x
Interest coverage4.73x

Cash quality & payout

Operating cash flow / net income1.21x
Accruals ratio-1.6%
Payout ratio—
Capex / revenue7.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.39B$1.25B
Cost of revenue$448.18M$399.95M
Gross profit$939.87M$853.48M
R&D expense$185.76M$182.51M
SG&A expense$548.81M$508.88M
Operating income$199.39M$129.05M
Interest expense$49.29M$63.07M
Pretax income-$220.78M$88.31M
Income tax$21.64M$25.06M
Net income-$242.47M$63.23M
EBITDA$227.95M$154.16M
EPS (basic)-4.451.17
EPS (diluted)-4.451.16
Weighted avg. shares (diluted)54.55M54.57M
Balance sheet
Cash & equivalents$635.55M$723.56M
Receivables$215.99M$193.16M
Inventory$164.70M$147.57M
Current assets$1.10B$1.13B
PP&E, net$242.60M$170.26M
Goodwill$792.84M$750.01M
Intangibles$229.96M$237.29M
Total assets$2.61B$2.51B
Current liabilities$808.07M$392.12M
Short-term debt$31.47M$78.00M
Long-term debt$345.19M$549.62M
Total debt$376.66M$627.63M
Total liabilities$1.41B$1.19B
Shareholders' equity$1.20B$1.32B
Net debt-$258.89M-$95.93M
Shares outstanding54.65M54.35M
Cash flow statement
Operating cash flow$254.34M$183.04M
Capital expenditure$81.05M$47.11M
Free cash flow$173.29M$135.93M
Investing cash flow-$72.91M-$48.16M
Financing cash flow-$285.66M$18.55M
Depreciation & amortization$28.56M$25.10M
Stock-based compensation$36.29M$33.93M

Free plan shows the latest 2 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.